Trivium Point Advisory’s Guardant Health GH Stock Holding History

Trivium Point Advisory’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$819K	Buy	5,457 +300	+6%	+$32.6K	0.07%	208
2026 Q1	$476K	Hold	5,157	–	–	0.09%	196
2025 Q4	$527K	Sell	5,157 -10	-0.2%	-$895	0.05%	235
2025 Q3	$323K	Buy	5,167 +385	+8%	+$20.9K	0.03%	287
2025 Q2	$249K	Buy	+4,782	New	+$214K	0.03%	305

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Trivium Point Advisory's GH Position: Q2 2026 in Review

Trivium Point Advisory increased its Guardant Health (GH) stake by 5.8% in Q2 2026, buying an estimated $32.6K and bringing the position to 5,457 shares worth $819K. The position accounts for 0.07% of the portfolio, ranked #208.

Trivium Point Advisory first reported a position in GH in Q2 2025 and has held it in 5 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Trivium Point Advisory held 5,457 shares of Guardant Health worth $819K as of Q2 2026.
Trivium Point Advisory bought 300 Guardant Health shares in Q2 2026, an estimated $32.6K.
Guardant Health made up 0.07% of Trivium Point Advisory's portfolio in Q2 2026, its #208 holding.
Trivium Point Advisory first reported a position in Guardant Health in Q2 2025 and has held it in 5 quarters since.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Trivium Point Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.